Tibolone vs combined HT
Cardiovascular events · postmenopausal women with or without vasomotor symptoms
It is very uncertain whether tibolone changes cardiovascular events (all doses) compared with combined HT (very low certainty).
1 finding from 1 review
- Short‐term and long‐term effects of tibolone in postmenopausal women 2016 · Cochrane Headline outcomes onlyOR 0.63 [0.24, 1.66]2 studies · 3794 participantsVery low